DOSAGE REGIMEN FOR 2-HYDROXY-6-((2- (1-ISOPROPYL-1H-PYRAZOL-5-YL)PYRIDIN-3-YL)METHOXY)BENZALDEHYDE

MA43373AUndetermined Publication Date: 2018-10-10GLOBAL BLOOD THERAPEUTICS INC
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
MA43373
Authority / Receiving Office
MA · MA
Patent Type
Applications
Current Assignee / Owner
Priority Date
2016-08-16
Filing Date
2016-12-02
Publication Date
2018-10-10
Patent Text Reader
Need to check novelty before this filing date? Find Prior Art
No text content released.